Genetic Technologies Ltd (GENE) Stock Analyst Earnings Estimates
NASDAQ:GENE - Nasdaq - US37185R4065 - ADR - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 6.795M 5,536.52% | 8.686M 27.83% | 7.665M -11.76% | |
| EBITDA YoY % growth | N/A | N/A | N/A | |
| EBIT YoY % growth | -7.57M 1.51% | -10.195M -34.68% | -10.615M -4.12% | |
| Operating Margin | -111.41% | -117.37% | -138.49% | |
| EPS YoY % growth | N/A | N/A | N/A |
All data in AUD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in AUD
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 3.706M -18.23% | % | ||
| Q2 2024 Q2Q % growth | 3.959M -4.70% | % | ||
| Q4 2023 Q2Q % growth | 4.532M -4.46% | % | ||
| Q2 2023 Q2Q % growth | 4.154M 102.53% | % | ||
| Q4 2022 Q2Q % growth | 4.744M 4,456.09% | % | ||
| Q2 2022 Q2Q % growth | 2.051M 12,375.79% | % | ||
| Q4 2021 Q2Q % growth | 104.12K 1,021.98% | % | ||
| Q2 2021 Q2Q % growth | 16.44K 2,686.44% | % | ||
| Q4 2020 Q2Q % growth | 9.28K 31.82% | % | ||
| Q2 2020 Q2Q % growth | 590 -96.79% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |